Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | +2.04% | -0.99% | -20.00% |
21/03 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
21/03 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 5.48M 457M | Sales 2025 * | 3.27M 273M | Capitalization | 60.1M 5.01B |
---|---|---|---|---|---|
Net income 2024 * | -85M -7.09B | Net income 2025 * | -94M -7.84B | EV / Sales 2024 * | 5.4 x |
Net cash position 2024 * | 30.52M 2.55B | Net Debt 2025 * | 25.18M 2.1B | EV / Sales 2025 * | 26.1 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-0.58
x | Employees | 63 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.5% |
Latest transcript on Kronos Bio, Inc.
1 day | +2.04% | ||
1 week | -0.99% | ||
Current month | -23.08% | ||
1 month | -23.08% | ||
3 months | -9.91% | ||
6 months | +18.39% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 01/18/01 | |
Joshua Kazam
FOU | Founder | 47 | 02/17/02 |
David Tanen
FOU | Founder | 52 | 02/17/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Tanen
FOU | Founder | 52 | 02/17/02 |
Joshua Kazam
FOU | Founder | 47 | 02/17/02 |
Arie Belldegrun
FOU | Founder | 74 | 02/17/02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1 | +2.04% | 442,883 |
25/24/25 | 0.98 | +2.08% | 765,478 |
24/24/24 | 0.96 | +1.05% | 904,416 |
23/24/23 | 0.95 | -1.04% | 4,308,192 |
22/24/22 | 0.96 | -4.95% | 173,041 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 60.1M | |
+1.51% | 42.75B | |
+48.15% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- KRON Stock